| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $70.1M | +23.8% |
| Cost of Revenue | $43.3M | +36.8% |
| R&D Expense | $18.3M | +5.9% |
| SG&A Expense | $24.0M | -46.0% |
| Operating Income | -$52.7M | +11.3% |
| Pre-tax Income | -$53.7M | +6.7% |
| Income Tax | $0 | -100.0% |
| Net Income | -$53.7M | +6.7% |
| EPS (Basic) | -$0.34 | +8.1% |
| EPS (Diluted) | -$0.34 | +8.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $34.6M | -50.7% |
| Accounts Receivable | $8.0M | -19.3% |
| Inventory | $15.3M | +6.1% |
| Current Assets | $64.9M | -50.1% |
| Total Assets | $106.8M | -45.6% |
| Current Liabilities | $28.2M | -50.6% |
| Long-term Debt | $4.6M | -20.3% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$35.9M | +52.4% |
| Capital Expenditures | $79K | -89.7% |
| Investing Cash Flow | $1.7M | -97.7% |
| Financing Cash Flow | -$1.2M | +94.4% |
| Free Cash Flow | -$36.0M | +52.8% |
| $48.8M |
| -42.8% |
| Stockholders' Equity | $58.0M | -47.8% |